0001179110-19-005746.txt : 20190508 0001179110-19-005746.hdr.sgml : 20190508 20190508202228 ACCESSION NUMBER: 0001179110-19-005746 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knowlton Calvin H CENTRAL INDEX KEY: 0001685833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37888 FILM NUMBER: 19808441 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc. CENTRAL INDEX KEY: 0001651561 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 465726437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 BUSINESS PHONE: 866-648-2767 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 4 1 edgar.xml FORM 4 - X0306 4 2019-05-07 0 0001651561 Tabula Rasa HealthCare, Inc. TRHC 0001685833 Knowlton Calvin H 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN NJ 08057 1 1 0 0 Chief Executive Officer Common Stock 2019-05-07 4 S 0 3741 52.94 D 900834 D Common Stock 2019-05-07 4 S 0 3529 54.09 D 897575 D Common Stock 2019-05-07 4 S 0 1000 55.00 D 896575 D Common Stock 807917 I Held by spouse. Common Stock 10000 I Held by trust for children. Common Stock 10000 I Held by trust for children. This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $52.42 to $53.31, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.58 to $54.56, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $54.81 to $55.53, inclusive. The reporting person received a restricted stock award of 337,307 shares of the Company's common stock on September 28, 2016. Pursuant to amendments to the restricted stock award on June 12, 2017 and May 30, 2018, respectively, 50% of such shares of common stock were scheduled to vest on May 31, 2019, with the remaining 50% of such shares of common stock scheduled to vest on January 31, 2020. Notwithstanding the foregoing, on May 2, 2019, the Company entered into an amendment to the restricted stock award with the reporting person and, pursuant thereto, all shares of common stock underlying such restricted stock award will now vest in six equal installments at the end of each calendar quarter beginning on June 30, 2019 and ending on September 30, 2020, such that the shares of common stock underlying such restricted stock award will be vested in full on September 30, 2020. /s/ Brian W. Adams, by Power of Attorney 2019-05-08